Rat dog micro-cap picks... Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks...

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Exotic	10/3/2009 10:27:00 AM
	Read Replies (1) of 48461

AVII..... online.barrons.com MONDAY, OCTOBER 5, 2009 FEATURE Unlocking the Code to New Treatments A SMALL SEATTLE-AREA BIOTECHNOLOGY company is tackling some tough diseases: Duchenne muscular dystrophy, as well as bioterror-virus threats Ebola and Marburg, coronary-artery blockage and swine flu. And now AVI BioPharma's lead drug for Duchenne is undergoing a key, early-stage clinical trial in the United Kingdom. Speculative investors may want to pay heed if it clears its next round of testing hurdles. The Duchenne drug is designed to work at the genetic level, using RNA (ribonucleic acid) "antisense" technology to induce production of dystrophin, a protein critical to healthy muscle cells. Lacking dystrophin, boys afflicted with Duchenne muscular dystrophy steadily lose ... ------- so this is what made the stock move, i suppose... and now will make it move up a lot more :-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next